Anika Therapeutics (NASDAQ:ANIK) detailed its fourth-quarter and full-year 2025 results and outlined its strategy for 2026 during its earnings call on Thursday, highlighting commercial-channel growth, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results